DOCSLIB.ORG

30 Years' German-Israeli Cooperation in Cancer Research 1976

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
30 Years' German-Israeli Cooperation in Cancer Research 1976 30 Years’ German-Israeli Cooperation in Cancer Research 1976 - 2006 Deutsches Krebsforschungszentrum Ministry of Science and Technology German Cancer Research Center State of Israel Heidelberg Jerusalem March 2006 > WEBbildschirm6kkk.pdf 1 10.03.2006 16:01:55 recent trends in research, such as stem cell research and a focus on clinical topics. Several principal investigators contributed to this brochure with reports of their projects. Many thanks go to these individuals and to all the principal investigators and Ph.D. students who have been part of the program. Their achievements and the personal contacts with their project partners have shaped the structure of our cooperation program. This anniversary brochure also gives a brief look at the history of the cooperation program. All the projects, including ongoing work, are listed in the appendix. The present brochure represents a follow up to our brochure Cancer Research and Cooperation, which was compiled in 1999, Professor Dr. Dr. Nurit Topaz Dr. Shlomo Sarig and summarizes the history and the development of our program. Re- Wolfhard Semmler Director for Israeli coordinator German coordinator German-Israeli Cooperations cently, the literature appendix was also updated to include all publications and reports up to 2004. These documents are available on our homepage (www.dkfz.de/israel). 30 Years' German-Israeli Cooperation in Cancer Research The coordinators would like to thank the BMBF for funding and the management board of the German Cancer Research Center for their support. A 30-year anniversary is something to be proud of and offers the opportunity to look back to the beginnings of the German-Israeli cooperation, which started in 1976 initially with three projects. The following phases showed an increase to Heidelberg/Jerusalem, March 2006 10 projects. Since receiving supplemental financing in 1992, a constant number of Prof. Dr. Dr. Wolfhard Semmler Dr. Shlomo Sarig Nurit Topaz 14 projects have been ongoing. As of June 2005, a total of 105 projects had been successfully concluded. The cooperation program has developed very satisfactorily in the course of the past 30 years, as certified by the international review commission in 1997. Outstanding achievements have been made in day-to-day work at the bench and in joint publications: Every year the project partners have reported on the progress of the respective subprojects at the annual meeting of the program committee so as to expand and intensify the cooperation. Indeed, more young scientists are being encouraged to apply for new projects and the priority topics reflect the most > > > WEBbildschirm6kkk.pdf 2 10.03.2006 16:01:56 Foreword I. 26 Contributions to the Cooperation Between Israeli Research Institutes and the Deutsches Krebsforschungszentrum 1. The Initiation of Metamorphosisby E. Shaaya and C. Sekeris >> 9. Carcinogens and Retroviruses – A Dangerous Liaison Regulation of synthesis of HnRNA in epidermis cells of insects by M. Löchelt >> and its posttranscriptional modification Tumorigenic cooperation between human retroviruses, 2. Loss of MHC – A Trick to Escape Immune Attack by G. Hämmerling >> oncogenes, and other carcinogens The immunobiology of tumor metastases & Tumor-associated blood 10. Lipid Profiles Characterize Tumor Cells by W. D. Lehmann vessel endothelium as a barrier to infiltration of effector immunocytes and W. E. Hull >> 3. What Makes Cancer Cells Migrate? by M. Zöller >> Development of NMR and mass spectroscopic techniques Escape mechanisms of metastatic tumor variants and their application in the investigation of fatty acid and phospholipid metabolism and alterations involved 4. Elucidating the Cause of DNA Amplification by J. Schlehofer >> in cellular transduction and malignant growth The role of DNA-amplification in tumor initiation 11. A Shared Passion for Growth Factors by R. Schwartz- 5. Monitoring Interleukin Production in Single Cells by R. Zawatzky >> Albiez >> Agents controlling the growth and differentiation of primitive blood Growth factor regulated interaction between lymphomyeloid/erythroid stem cells leukemias/lymphomas and endothelium 6. The Potential of Tumor Necrosis Factor by D. N. Männel >> 12. A Pacemaker of Inflammation by G. Fürstenberger >> Mechanisms controlling the response to tumor necrosis factor Regulation of gene expression in tumor growth: 7. The Opposing Effects of Interleukin 1 by M. Zöller >> Overexpression of prostaglandin H synthase iso- Cytokine secretion of tumor cells: Influence on tumor initiation zymes as potential markers for epithelial tumors and interaction with the immune system & The impact 13. Breaking Complement Resistance of Tumor cells – of host and tumor derived IL-1 on tumor growth and host defense A Novel Approach in Cancer Immunotherapy? 8. How Do Parvoviruses Kill Tumor Cells? by J. Schlehofer >> by M. Kirschfink >> Involvement of the NS genes in the antitumor activity of parvo- Molecular basis of the resistance of tumor cells to viruses complement-mediated lysis & Sensitization of human tumor cells to complement-mediated lysis 30 Years’ German-Israeli Cooperation in Cancer Research . Content 1 > > > 14. The Secret Functions of HBV Protein Xby Y. Shaul and 22. Elucidating the Function of HNF4γ by G. Schütz >> C. Schröder >> A biochemical and molecular genetic approach to study the Functional interaction of px of HBV with the tumor role of hepatocyte nuclear factor 4 (HNF4) and suppression suppressor p53 of tumor development by fatty acids 15. Guided Missiles Against Cancer Cells by M. Little >> 23. Integrin Signalling in Men and Mice by T. Tennenbaum Redirecting effector lymphocytes to lymphomas using and D. Breitkreutz >> chimeric receptors with antibody specificity The functional relevance of alterations in integrin α6β4 16. Enhanced Kinase Activity – A General Feature in Viral Carcino- and protein kinase C regulation in human and mouse skin genesis? by F. Rösl >> carcinogenesis Characterization of the biological effects of EGF/IGF 24. Resensitizing Tumors to Programmed Cell Death kinase inhibitors on the transcriptional regulation of by P. Krammer >> human papilloma viruses in immortalized keratinocytes The CD95 (APO-1/Fas) death system in tumor progression and cervical carcinomas 25. Insulin’s Role Beyond Sugar Metabolism by E. Wertheimer 17. The Role of p53-Mutations in Chemoresistance and D. Breitkreutz >> by P. Krammer >> Functional significance of insulin signaling in skin and skin The guardian of the genome, p53, and death receptor CD95 tumorigenesis 18. The Cell’s Response to Carcinogensby P. Angel >> 26. Cancer – A Consequence of Fragile Chromosomes? Identification of cellular pathways mediating cell death by M. Schwab >> in response to radiation and genotoxic agents Chromosomal fragile sites and cancer 19. Bone Protein Expression – A Prerequisite for Skeletal Metastasis? by M. R. Berger >> Development and evaluation of non-viral antisense oligo- II. DKFZ/MOST Cooperation in Cancer Research nucleotide and gene-controlled delivery systems for the History >> treatment of mammary carcinoma and bone osteolysis 20. Heparanase – A Novel Cancer-Specific T-cell-target? III. Appendix by V. Schirrmacher >> Tumor-metastasis-associated heparanase: A newly dis- Facts and Figures >> covered target recognized by memory T-lymphocytes of Masterplan, diagrams to finances, scientific publications, breast-cancer patients Israeli establishments involved, and list of all workshops 21. Triggering NK-Cell Killing of Tumor Cells by F. Momburg >> List of all projects >> Identification of the NKp46 ligand: A ligand that is involved Ca001 – 120 with running period, joint title, and partners in the recognition of virus-infected and tumor cells 30 Years’ German-Israeli Cooperation in Cancer Research . Content 2 > > > The Initiation of Metamorphosis shortly after the appearance of the small peak of ecdysone, but DOPA decar- boxylase is induced only after a second peak of ecdysone, induction being a Eli Shaaya and Costas Sekeris left their Mediterranean home- two-step process dependent on both peaks. Our experiments further lands to enter the fascinating world of science in Munich, suggested that only after the second surge of ecdysone there was more where the secrets of steroid hormone action were being un- genetic information transferred to the cytoplasm.The fact that a-amanitin, veiled at Peter Karlson’s lab. After some years of fruitful colla- the specific inhibitor of RNA polymerase II, injected before pupariation, boration, they parted but met again, this time in Heidelberg, inhibits RNA synthesis and the induction of the enzyme leads to the conclu- where Costas was heading the Division of Molecular Biology of the Cell at sion that the appearance of DOPA decarboxylase mRNA after the second the German Cancer Research Center (DKFZ). Eli visited him – two good ecdysone peak is a result of the stimulation of giant HnNA containing the friends happy to plan their new research project. So did the German-Israeli DOPA decarboxylase mRNA sequence and not of reutilization of preexisting collaboration 007, (a symbolic number indeed) start (Costas, in his capacity HnRNA. Our results appeared in Gen. Compar. Endocrin. 34:110, 1978 of Division Head, scientifically nurtured in Germany, although a Greek and Z. Physiol. Chem. 360:445, 1979. Shortly before the project was national, in every right represented the German side). The project was based selected, Eli returned to Israel, to the Hebrew University, where most of on our common interest in the mode of action of ecdysone, the steroid this
Load more

Recommended publications
  • The Interdisciplinary Center Herzliya
    המרכז הבינתחומי הרצליה The Interdisciplinary Center Herzliya The Interdisciplinary Center (IDC) Herzliya pays tribute to המרכז הבינתחומי הרצליה חולק כבוד ל־ MICHAEL SELA מיכאל סלע .Professor Michael Sela of the Weizmann Institute of Science is a world renowned immunologist פרופ' מיכאל סלע ממכון ויצמן למדע הוא מדען בעל שם עולמי בתחום האימונולוגיה )חקר מערכת His groundbreaking research has most notably led to the development of Copaxone, a drug used החיסון(. מחקריו פורצי הדרך, ובראשם פיתוח תרופת הקופקסון לטיפול בטרשת נפוצה, הקלו על .to treat multiple sclerosis that has helped ease the suffering of millions of patients worldwide חייהם של מיליוני חולים ברחבי העולם. Born in Poland in 1924, Prof. Sela earned his Bachelor and Master of Science degrees פרופ' מיכאל סלע, שנולד בפולין בשנת 1924, למד את התואר הראשון והשני במחלקה לכימיה from the School of Chemistry at the Hebrew University of Jerusalem, prior to focusing on life באוניברסיטה העברית בירושלים לפני שבחר לעסוק בתחום מדעי החיים. בשנת 1946, בעת שיצא sciences. In 1946, while studying in Switzerland, he assisted the Aliyah Bet’s efforts to help ללימודים בשווייץ, הוא פעל בשירות ההעפלה באיטליה. עם הקמת המדינה, הוא שימש כנספח Jews immigrate. After Israel’s inception, Prof. Sela, who is fluent in nine languages, served as מסחרי בצירות ישראל בצ'כוסלובקיה. צ'כית, למי שאינו יודע, היא רק אחת מבין תשע שפות שבהן .the commercial attaché at the Israeli mission to Czechoslovakia הוא שולט. After his return to Israel in 1950, Prof. Sela made the Weizmann Institute of Science his כאשר שב לארץ בשנת 1950, החל פרופ' מיכאל סלע את דרכו המחקרית במכון ויצמן למדע academic home.
    [Show full text]
  • Cv Prof. Yehuda Shoenfeld
    1 CV YEHUDA SHOENFELD, M.D., FRCP (Hon.) .MaACR CURRICULUM VITAE 2 0 2 0 Chaim Sheba Medical Center The Zabludowicz Center for Autoimmune Diseases Tel Hashomer 5265601, Israel. Former Incumbent of the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Sackler Faculty of Medicine, Tel-Aviv University, Israel. Tel: 03-5308070 Fax: 03-5352855 Mobile: 052-6669020 Tel. Home: 03- 5344877 Home Address: 26 Sapir St. Ramat-Gan 5265601 E-mail: [email protected] 2 CURRICULUM VITAE YEHUDA SHOENFELD, M.D. Date and place of birth: February 14, 1948, Slovakia. Marital Status: Married to Irit + 3 (Nettea, Amir, Guy) EDUCATION AND APPOINTMENTS 1965 - 1972 Hadassah Medical School, Hebrew University, Jerusalem 1972 - M.D. Thesis: "Osteogenesis Imperfecta" (Advisor: Prof. A. Fried) cum laude 1976 - 1978 Diploma cum laude upon completion of post graduate studies in internal medicine, Postgraduate Medical School, Tel Aviv University 1976 - 1978 Senior resident, Department of Internal Medicine "D" and Out-Patient Clinic of Hematology and Immunology, Beilinson Medical Center, Petach Tikva, Israel 1978 (3m) - Clinical Fellowship, Hematology/Oncology, Department of Hematology, City of Hope, Duarte, California (Director: Prof. E. Beutler) 1979 (3m) - Clinical Fellowship Hematology/Oncology, Tufts New England Medical Center, Boston, Mass. (Director: Prof. Robert S. Schwartz) 1980 (3m) - Clinical Fellowship Hematology/Oncology, Cornell Medical Center, New York Hospital (Director: Prof. R. Nachman) 1980 - Master in Internal Medicine, Postgraduate
    [Show full text]
  • Wellcome Witnesses to Twentieth Century Medicine
    WELLCOME WITNESSES TO TWENTIETH CENTURY MEDICINE _______________________________________________________________ TECHNOLOGY TRANSFER IN BRITAIN: THE CASE OF MONOCLONAL ANTIBODIES ______________________________________________ SELF AND NON-SELF: A HISTORY OF AUTOIMMUNITY ______________________ ENDOGENOUS OPIATES _____________________________________ THE COMMITTEE ON SAFETY OF DRUGS __________________________________ WITNESS SEMINAR TRANSCRIPTS EDITED BY: E M TANSEY P P CATTERALL D A CHRISTIE S V WILLHOFT L A REYNOLDS Volume One – April 1997 CONTENTS WHAT IS A WITNESS SEMINAR? i E M TANSEY TECHNOLOGY TRANSFER IN BRITAIN: THE CASE OF MONOCLONAL ANTIBODIES EDITORS: E M TANSEY AND P P CATTERALL TRANSCRIPT 1 INDEX 33 SELF AND NON-SELF: A HISTORY OF AUTOIMMUNITY EDITORS: E M TANSEY, S V WILLHOFT AND D A CHRISTIE TRANSCRIPT 35 INDEX 65 ENDOGENOUS OPIATES EDITORS: E M TANSEY AND D A CHRISTIE TRANSCRIPT 67 INDEX 100 THE COMMITTEE ON SAFETY OF DRUGS EDITORS: E M TANSEY AND L A REYNOLDS TRANSCRIPT 103 INDEX 133 WHAT IS A WITNESS SEMINAR? Advances in medical science and medical practice throughout the twentieth century, and especially after the Second World War, have proceeded at such a pace, and with such an intensity, that they provide new and genuine challenges to historians. Scientists and clinicians themselves frequently bemoan the rate at which published material proliferates in their disciplines, and the near impossibility of ‘keeping up with the literature’. Pity, then, the poor historian, trying to make sense of this mass of published data, scouring archives for unpublished accounts and illuminating details, and attempting throughout to comprehend, contextualize, reconstruct and convey to others the stories of the recent past and their significance. The extensive published record of modern medicine and medical science raises particular problems for historians: it is often presented in a piecemeal but formal fashion, sometimes seemingly designed to conceal rather than reveal the processes by which scientific medicine is conducted.
    [Show full text]
  • President's Report 2018
    VISION COUNTING UP TO 50 President's Report 2018 Chairman’s Message 4 President’s Message 5 Senior Administration 6 BGU by the Numbers 8 Building BGU 14 Innovation for the Startup Nation 16 New & Noteworthy 20 From BGU to the World 40 President's Report Alumni Community 42 2018 Campus Life 46 Community Outreach 52 Recognizing Our Friends 57 Honorary Degrees 88 Board of Governors 93 Associates Organizations 96 BGU Nation Celebrate BGU’s role in the Israeli miracle Nurturing the Negev 12 Forging the Hi-Tech Nation 18 A Passion for Research 24 Harnessing the Desert 30 Defending the Nation 36 The Beer-Sheva Spirit 44 Cultivating Israeli Society 50 Produced by the Department of Publications and Media Relations Osnat Eitan, Director In coordination with the Department of Donor and Associates Affairs Jill Ben-Dor, Director Editor Elana Chipman Editorial Staff Ehud Zion Waldoks, Jacqueline Watson-Alloun, Angie Zamir Production Noa Fisherman Photos Dani Machlis Concept and Design www.Image2u.co.il 4 President's Report 2018 Ben-Gurion University of the Negev - BGU Nation 5 From the From the Chairman President Israel’s first Prime Minister, David Ben–Gurion, said:“Only Apartments Program, it is worth noting that there are 73 This year we are celebrating Israel’s 70th anniversary and Program has been studied and reproduced around through a united effort by the State … by a people ready “Open Apartments” in Beer-Sheva’s neighborhoods, where acknowledging our contributions to the State of Israel, the the world and our students are an inspiration to their for a great voluntary effort, by a youth bold in spirit and students live and actively engage with the local community Negev, and the world, even as we count up to our own neighbors, encouraging them and helping them strive for a inspired by creative heroism, by scientists liberated from the through various cultural and educational activities.
    [Show full text]
  • Proceedings of the American Philosophical Society Vol. 120, Num
    Proceedings of the American Philosophical Society Vol. 120, Num. 1. Año 1976 Held at Philadelphia for Promoting Useful Knowledge Fred L. Whipple. “Comet Kohoutek in Retrospect” Proceedings of the American Philosophical Society. Vol. 120, Num. 1. Año 1976; pagina 1-6 Myron P. Gilmore. “The Berensons and Villa I Tatti” Proceedings of the American Philosophical Society. Vol. 120, Num. 1. Año 1976; pagina 7-12 Helen B. Taussig. “The Development of the Blalock-Taussing Operation and Its Results Twenty Years Later” Proceedings of the American Philosophical Society. Vol. 120, Num. 1. Año 1976; pagina 13-20 Ward H. Goodenough. “On the Origin of Matrilineal Clans: A “Just So” Story” Proceedings of the American Philosophical Society. Vol. 120, Num. 1. Año 1976; pagina 21-36 Leon N. Cooper. “How Possible Becomes Actual in the Quantum Theory” Proceedings of the American Philosophical Society. Vol. 120, Num. 1. Año 1976; pagina 37-45 John Owen King. “Labors of the Estranged Personality: Josiah Royce on “The Case of John Bunyan”” Proceedings of the American Philosophical Society. Vol. 120, Num. 1. Año 1976; pagina 46-58 Stanley A. Czarnik. “The Theory of the Mesolithic in European Archaeology” Proceedings of the American Philosophical Society. Vol. 120, Num. 1. Año 1976; pagina 59-66 Proceedings of the American Philosophical Society Vol. 120, Num. 2. Año 1976 Held at Philadelphia for Promoting Useful Knowledge Jonathan E. Rhoads. “New Approaches in the Study of Neoplasia: Preliminary Remarks for the Symposium” Proceedings of the American Philosophical Society. Vol. 120, Num. 2. Año 1976; pagina 67-68 Sol Spiegelman. “The Search for Viruses in Human Cancer” Proceedings of the American Philosophical Society.
    [Show full text]
  • Download Oral Program
    Cell-Weizmann Institute of Science Symposium: Next Gen Immunology | Oral Program Oral Program Sunday, February 11 2018 08:00-11:00 Registration | The David Lopatie Conference Centre 11:00-11:20 Welcome and Introduction Session 1: Cellular and Organismal Homeostasis| The Michael and Anna Wix Auditorium Chairs: Yehudit Bergman, The Hebrew University of Jerusalem, Israel; Scott Plevy, Janssen Pharmaceuticals, Inc, USA 11:20-12:00 With a little help from our friends Ruslan Medzhitov, Yale University, USA [INV01] 12:00-12:30 Phagocyte responses to dying cells Julie Magarian Blander, Weill Cornell Medical College, USA [INV02] 12:30-13:00 The power of ONE: Immunology in the age of single cell genomics Ido Amit, Weizmann Institute of Science, Israel [INV03] 13:00-14:20 Lunch | The David Lopatie Conference Centre 14:20-14:35 Human dendritic cells: From development to functions Florent Ginhoux, Singapore Immunology Network (SIgN), A*STAR, Singapore [ST01] 14:35-15:05 Host genetics and barrier function in gut inflammation Ramnik Xavier, Broad Institute of MIT and Harvard [INV42] 15:05-15:35 Human Lupus: Adding new pieces to the puzzle Virginia Pascual, Weill Cornell Medical College, USA [INV05] 15:35-16:05 Western diet triggers a NLRP3-dependent persistent functional reprograming of myeloid cells Eicke Latz*1-4, A. Christ1,2, 1University of Bonn, Germany, 2 UMass Medical School, USA, 3 Norwegian University of Science and Technology, Norway, 4German Center for Neurodegenerative Diseases, Germany [INV06] 16:05-16:35 Refreshment Break | The David Lopatie
    [Show full text]
  • A History of the ASBMB Annual Meeting
    COMPETE FOR BEST POSTER AWARDS IN ANAHEIM September 2009 A History of the ASBMB Annual Meeting American Society for Biochemistry and Molecular Biology ASBMB Annual Meeting Get Ready to Meet in California! Anaheim Awaits April 24–28, 2010 www.asbmb.org/meeting2010 Travel Awards and Abstract Submission Deadline: November 4th, 2009 Registration Open September 2009 AnaheimAd FINAL.indd 1 6/15/09 1:00:42 PM contents SEPTEMBER 2009 On the Cover: A look at the history of the ASBMB Annual society news Meeting. 2 President’s Message 22 6 News from the Hill 9 Washington Update 10 Retrospective: Ephraim Katchalski Katzir (1916-2009) JBC minireview 13 JBC Highlights Computational series looks at computational Biochemistry biochemistry. 14 Member Spotlight 13 special interest 16 Lifting the Veil on Biological Research 18 Mildred Cohn: Isotopic and Spectroscopic Trailblazer 22 History of the ASBMB Annual Meeting 2010 annual meeting 26 The Chemistry of Life A profile of 28 New Frontiers in Genomics ASBMB’s first and Proteomics woman president, Mildred Cohn. 30 Hypertension: Molecular 18 Mechanisms, Treatment and Disparities departments 32 Minority Affairs 33 Lipid News 34 BioBits 36 Career Insights 38 Education and Training resources Scientific Meeting Calendar erratum online only The article on the 2009 ASBMB election results in the August issue of ASBMB Today mistakenly identified Charles Brenner as professor and head of the Biochemistry Department at Dartmouth Medical School. He is, in fact, head of biochemistry at University of Iowa’s Carver College of Medicine. September 2009 ASBMB Today 1 president’smessage A monthly publication of The American Society for Biochemistry and Molecular Biology Wimps? Officers Gregory A.
    [Show full text]
  • A Symposium in Honor of the 80Th Birthday of Prof. Israel Pecht
    A Symposium in Honor of the 80th Birthday of Prof. Israel Pecht June 29th, 2017 Molecular Recognition, The David Lopatie Conference Centre Signaling and Function Weizmann Institute of Science Program 14:00-15:40 - SESSION 3 Chairs: Laszlo Fesus, University of Debrecen, Debrecen, Hungary 08:30-09:00 Registration Peter Kroneck, University of Konstanz, Konstanz, Germany 14:05 Alexander Levitzki, Hebrew University, Jerusalem, Israel 09:00-09:15 - OPENING SESSION Targeting the immune system to tumours Daniel Zajfman, President, Weizmann Institute of Science, Rehovot, Israel 14:35 Maurizio Brunori, La Sapienza University, Rome, Italy Michael Sela, Weizmann Institute of Science, Rehovot, Israel Protein frustration between folding and function 09:15 -10:50 - SESSION 1 15:05-15:40 - SESSION 4 Chairs: Ulrich Kubitscheck, University of Bonn, Bonn, Germany Chair: Ruth Arnon, Weizmann Institute of Science, Rehovot, Israel Miguel de la Rosa, University of Seville, Seville, Spain 15:10 Helga Nowotny, ERA Council Forum, Vienna, Austria 09:20 Harry Gray, California Institute of Technology, California, USA Navigating uncertainty: the usefulness of useless knowledge Living with Oxygen 15:40-16:00 Coffee break 09:50 Daniella Goldfarb, Weizmann Institute of Science, Rehovot, Israel 16:00-18:00 - SESSION 5 The electron transfer mediating copper site in azurin - spectroscopic digging into its unique electronic structure Chairs: Anna Erdei, Eötvös Loránd University, Budapest, Hungary V. Horejsi, Institute of Molecular Genetics, Czech Academy of 10:20 David Cahen,
    [Show full text]
  • Progress in Immunology Vol
    Progress in Immunology Vol. VII Proceedings of the 7th International Congress of Immunology Berlin 1989 Editors: F. Melchers E.D. Albert, H. von Boehmer, M.P. Dierich, L. Du Pasquier, K. Eichmann, D. Gemsa, O. Gotze, J.R. Kalden, S.H.E. Kaufmann, H. Kirchner, K. Resch, G. Riethmiiller, A. Schimpl, C. Sorg, M. Steinmetz, H. Wagner, H. G. Zachau Editorial Assistance: L. Nicklin With 255 Figures and 184 Tables Springer-Verlag Berlin Heidelberg New York London Paris Tokyo Hong Kong FRITZ MELCHERS Basel Institute for Immunology Grenzacherstrasse 487 4005 Basel, Switzerland Names and addresses of the other editors can be found on page LX ISBN-13 : 978-3-642-83757-9 e-ISBN-t3 : 978-3-642-83755-5 DOl : 10.1007 /978-3-642-83755-5 Library of Congress Catalog Card Number 19-640888 This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, re-use of illustrations, recitation, broadcasting, reproduction on microfilms or in other ways, and storage in data banks. Duplication of this publication or parts thereof is only permitted under the provisions of the German Copyright Law of September 9, 1965, in its version of June 24,1985, and a copyright fee must always be paid. Violations fall under the prosecution act of the German Copyright Law. © Springer-Verlag Berlin Heidelberg 1989 Softcover reprint of the hardcover I st edition 1989 The use of general descriptive names, registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use.
    [Show full text]
  • TWIM Fall 2016
    FALL 2016 WEIZMANN MAGAZINE FALL 2016 No. 10 VOLUME 10 The immune system The body’s police force The future of the past Judy and David Dangoor’s passion for archaeology The Schwartz-Reisman Institute for Theoretical Physics From the President Dear Friends, When the New York Times recently ran an in-depth series of articles about the promise of immunotherapy, we were not surprised. After all, immunotherapy has been the focus of keen scientific interest here at the Weizmann Institute for years, with some of the world’s most important immunotherapy-related discoveries emerging from our labs, both historically and right up to the present day. In fact, it was our recognition of the dynamism of the field that inspired us to choose the topic of this magazine’s cover story: an overview of the Weizmann Institute’s contribution to both immunology research and breakthroughs in immunotherapy for cancer. When Prof. Zelig Eshhar of the Institute’s Department of Immunology began exploring how genetic modification of immune cells could cause such cells to seek out and destroy cancer back in the 1980s, he was in the company of just a few other scientists worldwide convinced of cancer immunotherapy’s potential. Today this hoped-for potential is “settled science” and Prof. Eshhar’s T-cell research, which is now the basis for a successful drug therapy for leukemia, is just the latest success from our renowned scientists working in immunotherapy- related topics—a group that includes Prof. Michael Sela, Prof. Ruth Arnon, and others. Credits One of the stories to which I’d like to draw your attention describes A publication of the Department the establishment of the Schwartz-Reisman Institute for Theoretical of Resource Development Physics.
    [Show full text]
  • General Kofi A. Annan the United Nations United Nations Plaza
    MASSACHUSETTS INSTITUTE OF TECHNOLOGY DEPARTMENT OF PHYSICS CAMBRIDGE, MASSACHUSETTS O2 1 39 October 10, 1997 HENRY W. KENDALL ROOM 2.4-51 4 (617) 253-7584 JULIUS A. STRATTON PROFESSOR OF PHYSICS Secretary- General Kofi A. Annan The United Nations United Nations Plaza . ..\ U New York City NY Dear Mr. Secretary-General: I have received your letter of October 1 , which you sent to me and my fellow Nobel laureates, inquiring whetHeTrwould, from time to time, provide advice and ideas so as to aid your organization in becoming more effective and responsive in its global tasks. I am grateful to be asked to support you and the United Nations for the contributions you can make to resolving the problems that now face the world are great ones. I would be pleased to help in whatever ways that I can. ~~ I have been involved in many of the issues that you deal with for many years, both as Chairman of the Union of Concerne., Scientists and, more recently, as an advisor to the World Bank. On several occasions I have participated in or initiated activities that brought together numbers of Nobel laureates to lend their voices in support of important international changes. -* . I include several examples of such activities: copies of documents, stemming from the . r work, that set out our views. I initiated the World Bank and the Union of Concerned Scientists' examples but responded to President Clinton's Round Table initiative. Again, my appreciation for your request;' I look forward to opportunities to contribute usefully. Sincerely yours ; Henry; W.
    [Show full text]
  • Yearbook 2004 Yearbook 2004
    COVER((OK)) 22-09-2004 12:00 Pagina 1 PONTIFICIA ACADEMIA SCIENTIARVM PONTIFICIA ACADEMIASCIENTIARVM YEARBOOK 2004 YEARBOOK 2004 VATICAN CITY 01_Prima Parte+BIO.A_1.Prima Parte 25/06/10 10:34 Pagina 1 THE PONTIFICAL ACADEMY OF SCIENCES Yearbook 2004 Vatican City 01_Prima Parte+BIO.A_1.Prima Parte 25/06/10 10:34 Pagina 2 ‘Truth, freedom and responsibility are connected in the experience of the sci- entist. In setting out on his path of research, he understands that he must tread not only with the impartiality required by the objectivity of his method but also with the intellectual honesty, the responsibility, and I would say with a kind of “reverence”, which befit the human spirit in its drawing near to truth. For the scientist, to understand in an ever better way the particular reality of man in relation to the biological-physical processes of nature, to discover always new aspects of the cosmos, to know more about the location and the distri- bution of resources, the social and environmental dynamics, and the logic of progress and development, becomes translated into a duty to serve more fully the whole of mankind, to which he belongs. For this reason, the ethical and moral responsibilities connected to scientific research can be perceived as a requirement within science, because it is a fully human activity, but not as control, or worse, as an imposition which comes from outside. The man of science knows perfectly, from the point of view of his knowledge, that truth cannot be subject to negotiation, cannot be obscured or abandoned to free conventions or agreements between groups of power, societies, or States.
    [Show full text]